Lipitor and Type 2 Diabetes in Women

admin » 25 July 2013 » In FDA, Mass Tort »

Women taking Lipitor have an increased risk of being diagnosed with type 2 diabetes. Lipitor (atorvastatin calcium) has been widely prescribed to regulate cholesterol and blood pressure since 1996. More than 29 million people in the United States have been prescribed the drug, according to Pfizer’s website.

In February 2012, the Food and Drug Administration (FDA) approved a warning label change for the drug, to include an increased risk for type 2 diabetes. Their decision was prompted by a clinical trial conducted in 2011, which found that people taking Lipitor had an increased risk of developing type 2 diabetes.

That study suggested that the increased risk was largely attributable to the fact that women with high blood sugar, high blood pressure and other known risk factors for type 2 diabetes were already predisposed to developing the disease. However, another study published in May 2013 in the British Medical Journal more clearly established a link between Lipitor and diabetes.

The study found that people treated with Lipitor, in comparison to other statins, including Zocor and Crestor, were 22 percent more likely to develop new onset diabetes. Of all the statins tested in the study, Lipitor had the highest incidence of diabetes.


Tags: ,

Trackback URL

No Comments on "Lipitor and Type 2 Diabetes in Women"

Hi Stranger, leave a comment:


<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Subscribe to Comments